NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension
offering product urn:matchory:offering:01m772jz1wexg958fcgad5w3rc
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51303400 Antifungal triazoles (class).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension | products products 2 | NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspensionhttps://www.merck.com/products/ |
2026-11-12 | current |
| Name as stated name | NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension | extraction extract 3 | NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspensionhttps://www.merck.com/products/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51303400 (16 candidates considered) (0.95) | classification unspsc 3 | 2026-11-12 | current |